Immunic, Inc. · NASDAQ:IMUX
Commodore Capital LP reported a 9.90% stake in Immunic, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Commodore Capital LP reported a 9.90% stake in Immunic, Inc., 1,511,821 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 1,511,821
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.90% | 1,511,821 |
| Commodore Capital Master LP | 9.90% | 1,511,821 |
| Robert Egen Atkinson | 9.90% | 1,511,821 |
| Michael Kramarz | 9.90% | 1,511,821 |
Source
Related
- Immunic, Inc.
- Commodore Capital LP
- Immunic, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 6, 2026
- Schedule 13G · Laurion Capital Management LP · Aug 4, 2026
- Schedule 13G/A · Aberdeen Group plc · Jul 16, 2026